# Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections

> **NCT00685698** · PHASE2 · COMPLETED · sponsor: **TaiGen Biotechnology Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Diabetic Foot Infections

## Interventions

- **DRUG:** TG-873870 (Nemonoxacin)

## Key facts

- **NCT ID:** NCT00685698
- **Lead sponsor:** TaiGen Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-04
- **Final completion:** 2009-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00685698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00685698, "Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00685698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*